Necrotizing Soft Tissue Infections



Necrotizing soft tissue infection (NSTI) is a rare disease primarily affecting middle- and older-aged individuals. No predisposing risk factor is identified in a high percentage of patients. Mortality rates have not improved significantly over the past century. Amputation rates are high and multiple debridements are the rule. Wide surgical debridement is the only effective therapy for NSTI and that time is of the utmost essence. Mortality remains between 10 and 30 % and long-term disability is common.


Positive Predictive Value Necrotizing Fasciitis Amputation Rate Staphylococcal Scald Skin Syndrome Necrotizing Soft Tissue Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Descamps V, Aitken J, Lee MG. Hippocrates on necrotising fasciitis. Lancet. 1994;344(8921):556.PubMedCrossRefGoogle Scholar
  2. 2.
    Pace A, van den Spiegel A. The Workes of that Famous Chururgian Ambrose Parey. In: Clarke J, editor. The Complutense University of Madrid (trans: Johnson T). R. Cotes and Willi Dugard; 2011, pp. 837.Google Scholar
  3. 3.
    Salcido RS. Necrotizing fasciitis: reviewing the causes and treatment strategies. Adv Skin Wound Care. 2007;20(5):288–93, quiz 294–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Green RJ, Dafoe DC, Raffin TA. Necrotizing fasciitis. Chest. 1996;110(1):219–29.PubMedCrossRefGoogle Scholar
  5. 5.
    Phan HH, Cocanour CS. Necrotizing soft tissue infections in the intensive care unit. Crit Care Med. 2010;38(9 Suppl):S460–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Quirk Jr WF, Sternbach G. Joseph Jones: infection with flesh eating bacteria. J Emerg Med. 1996;14(6):747–53.PubMedCrossRefGoogle Scholar
  7. 7.
    Meleney F. Hemolytic Streptococcus Gangrene. Arch Surg. 1924;9:317–64.CrossRefGoogle Scholar
  8. 8.
    May AK. Skin and soft tissue infections. Surg Clin North Am. 2009;89(2):403–20, viii.PubMedCrossRefGoogle Scholar
  9. 9.
    Anaya DA, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis. 2007;44(5):705–10.PubMedCrossRefGoogle Scholar
  10. 10.
    Kaul R, et al. Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. Am J Med. 1997;103(1):18–24.PubMedCrossRefGoogle Scholar
  11. 11.
    McHenry CR, et al. Determinants of mortality for necrotizing soft-tissue infections. Ann Surg. 1995;221(5):558–63; discussion 563–5.PubMedCrossRefGoogle Scholar
  12. 12.
    Elliott D, Kufera JA, Myers RA. The microbiology of necrotizing soft tissue infections. Am J Surg. 2000;179(5):361–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Su YC, et al. Laboratory risk indicator for necrotizing fasciitis score and the outcomes. ANZ J Surg. 2008;78(11):968–72.PubMedCrossRefGoogle Scholar
  14. 14.
    Zacharias N, et al. Diagnosis of necrotizing soft tissue infections by computed tomography. Arch Surg. 2010;145(5):452–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Wall DB, et al. A simple model to help distinguish necrotizing fasciitis from nonnecrotizing soft tissue infection. J Am Coll Surg. 2000;191(3):227–31.PubMedCrossRefGoogle Scholar
  16. 16.
    Kao LS, et al. Local variations in the epidemiology, microbiology, and outcome of necrotizing soft-tissue infections: a multicenter study. Am J Surg. 2011;202(2):139–45.PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Huang KF, et al. Independent predictors of mortality for necrotizing fasciitis: a retrospective analysis in a single institution. J Trauma. 2011;71(2):467–73; discussion 473.PubMedCrossRefGoogle Scholar
  18. 18.
    Das DK, Baker MG, Venugopal K. Increasing incidence of necrotizing fasciitis in New Zealand: a nationwide study over the period 1990 to 2006. J Infect. 2011;63(6):429–33.PubMedCrossRefGoogle Scholar
  19. 19.
    Mulla ZD, Gibbs SG, Aronoff DM. Correlates of length of stay, cost of care, and mortality among patients hospitalized for necrotizing fasciitis. Epidemiol Infect. 2007;135(5):868–76.PubMedCrossRefGoogle Scholar
  20. 20.
    Singh G, et al. Necrotising infections of soft tissues – a clinical profile. Eur J Surg. 2002;168(6):366–71.PubMedCrossRefGoogle Scholar
  21. 21.
    Anaya DA, et al. Predictors of mortality and limb loss in necrotizing soft tissue infections. Arch Surg. 2005;140(2):151–7; discussion 158.PubMedCrossRefGoogle Scholar
  22. 22.
    Childers BJ, et al. Necrotizing fasciitis: a fourteen-year retrospective study of 163 consecutive patients. Am Surg. 2002;68(2):109–16.PubMedGoogle Scholar
  23. 23.
    Wong CH, et al. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am. 2003;85-A(8):1454–60.PubMedGoogle Scholar
  24. 24.
    Brandt MM, Corpron CA, Wahl WL. Necrotizing soft tissue infections: a surgical disease. Am Surg. 2000;66(10):967–70; discussion 970–1.PubMedGoogle Scholar
  25. 25.
    Hsiao CT, et al. Predictors of mortality in patients with necrotizing fasciitis. Am J Emerg Med. 2008;26(2):170–5.PubMedCrossRefGoogle Scholar
  26. 26.
    Yilmazlar T, et al. Necrotizing soft tissue infections: APACHE II score, dissemination, and survival. World J Surg. 2007;31(9):1858–62.PubMedCrossRefGoogle Scholar
  27. 27.
    Endorf FW, Supple KG, Gamelli RL. The evolving characteristics and care of necrotizing soft-tissue infections. Burns. 2005;31(3):269–73.PubMedCrossRefGoogle Scholar
  28. 28.
    Light TD, et al. Long-term outcomes of patients with necrotizing fasciitis. J Burn Care Res. 2010;31(1):93–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Kobayashi L, et al. Necrotizing soft tissue infections: delayed surgical treatment is associated with increased number of surgical debridements and morbidity. J Trauma. 2011;71(5):1400–5.PubMedCrossRefGoogle Scholar
  30. 30.
    Bosshardt TL, Henderson VJ, Organ Jr CH. Necrotizing soft-tissue infections. Arch Surg. 1996;131(8):846–52; discussion 852–4.PubMedCrossRefGoogle Scholar
  31. 31.
    Liu YM, et al. Microbiology and factors affecting mortality in necrotizing fasciitis. J Microbiol Immunol Infect. 2005;38(6):430–5.PubMedGoogle Scholar
  32. 32.
    Pessa ME, Howard RJ. Necrotizing fasciitis. Surg Gynecol Obstet. 1985;161(4):357–61.PubMedGoogle Scholar
  33. 33.
    Elliott DC, Kufera JA, Myers RA. Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann Surg. 1996;224(5):672–83.PubMedCrossRefGoogle Scholar
  34. 34.
    Anaya DA, et al. Predicting death in necrotizing soft tissue infections: a clinical score. Surg Infect (Larchmt). 2009;10(6):517–22.CrossRefGoogle Scholar
  35. 35.
    Tillou A, et al. Necrotizing soft tissue infections: improved outcomes with modern care. Am Surg. 2004;70(10):841–4.PubMedGoogle Scholar
  36. 36.
    Lee CC, et al. Necrotizing fasciitis in patients with liver cirrhosis: predominance of monomicrobial Gram-negative bacillary infections. Diagn Microbiol Infect Dis. 2008;62(2):219–25.PubMedCrossRefGoogle Scholar
  37. 37.
    Lee TC, et al. Incidence and clinical characteristics of methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a large urban hospital. Am J Surg. 2007;194(6):809–12; discussion 812–3.PubMedCrossRefGoogle Scholar
  38. 38.
    Sarani B, et al. Necrotizing fasciitis: current concepts and review of the literature. J Am Coll Surg. 2009;208(2):279–88.PubMedCrossRefGoogle Scholar
  39. 39.
    Voros D, et al. Role of early and extensive surgery in the treatment of severe necrotizing soft tissue infection. Br J Surg. 1993;80(9):1190–1.PubMedCrossRefGoogle Scholar
  40. 40.
    Wong CH, Wang YS. The diagnosis of necrotizing fasciitis. Curr Opin Infect Dis. 2005;18(2):101–6.PubMedCrossRefGoogle Scholar
  41. 41.
    NIH. Highly invasive new bacterium isolated from US east coast waters. JAMA. 1984;251(3):323–5.CrossRefGoogle Scholar
  42. 42.
    Cainzos M, Gonzalez-Rodriguez FJ. Necrotizing soft tissue infections. Curr Opin Crit Care. 2007;13(4):433–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Stone DR, Gorbach SL. Necrotizing fasciitis. The changing spectrum. Dermatol Clin. 1997;15(2):213–20.PubMedCrossRefGoogle Scholar
  44. 44.
    Miller LG, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med. 2005;352(14):1445–53.PubMedCrossRefGoogle Scholar
  45. 45.
    Dunbar NM, Harruff RC. Necrotizing fasciitis: manifestations, microbiology and connection with black tar heroin. J Forensic Sci. 2007;52(4):920–3.PubMedCrossRefGoogle Scholar
  46. 46.
    Tovi F, Fliss DM, Zirkin HJ. Necrotizing soft-tissue infections in the head and neck: a clinicopathological study. Laryngoscope. 1991;101(6 Pt 1):619–25.PubMedGoogle Scholar
  47. 47.
    Maisel RH, Karlen R. Cervical necrotizing fasciitis. Laryngoscope. 1994;104(7):795–8.PubMedCrossRefGoogle Scholar
  48. 48.
    Hsieh RL, Huang CH, Uen WC. Necrotizing fasciitis after acupuncture in a patient with aplastic anemia. J Altern Complement Med. 2011;17(9):871–4.PubMedCrossRefGoogle Scholar
  49. 49.
    Eke N. Fournier’s gangrene: a review of 1726 cases. Br J Surg. 2000;87(6):718–28.PubMedCrossRefGoogle Scholar
  50. 50.
    Rea WJ, Wyrick Jr WJ. Necrotizing fasciitis. Ann Surg. 1970;172(6):957–64.PubMedCrossRefGoogle Scholar
  51. 51.
    Brook I, Frazier EH. Clinical and microbiological features of necrotizing fasciitis. J Clin Microbiol. 1995;33(9):2382–7.PubMedCentralPubMedGoogle Scholar
  52. 52.
    Yen ZS, et al. Ultrasonographic screening of clinically-suspected necrotizing fasciitis. Acad Emerg Med. 2002;9(12):1448–51.PubMedCrossRefGoogle Scholar
  53. 53.
    Butcher CH, Dooley RW, Levitov AB. Detection of subcutaneous and intramuscular air with sonography: a sensitive and specific modality. J Ultrasound Med. 2011;30(6):791–5.PubMedGoogle Scholar
  54. 54.
    Schmid MR, Kossmann T, Duewell S. Differentiation of necrotizing fasciitis and cellulitis using MR imaging. AJR Am J Roentgenol. 1998;170(3):615–20.PubMedCrossRefGoogle Scholar
  55. 55.
    Brothers TE, et al. Magnetic resonance imaging differentiates between necrotizing and non-necrotizing fasciitis of the lower extremity. J Am Coll Surg. 1998;187(4):416–21.PubMedCrossRefGoogle Scholar
  56. 56.
    Wong CH, et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32(7):1535–41.PubMedCrossRefGoogle Scholar
  57. 57.
    Edlich RF, et al. Modern concepts of the diagnosis and treatment of necrotizing fasciitis. J Emerg Med. 2010;39(2):261–5.PubMedCrossRefGoogle Scholar
  58. 58.
    Stamenkovic I, Lew PD. Early recognition of potentially fatal necrotizing fasciitis. The use of frozen-section biopsy. N Engl J Med. 1984;310(26):1689–93.PubMedCrossRefGoogle Scholar
  59. 59.
    Heinle EC, et al. The use of 5% mafenide acetate solution in the postgraft treatment of necrotizing fasciitis. J Burn Care Rehabil. 2001;22(1):35–40.PubMedCrossRefGoogle Scholar
  60. 60.
    Jallali N, Withey S, Butler PE. Hyperbaric oxygen as adjuvant therapy in the management of necrotizing fasciitis. Am J Surg. 2005;189(4):462–6.PubMedCrossRefGoogle Scholar
  61. 61.
    Sheridan RL, Shank ES. Hyperbaric oxygen treatment: a brief overview of a controversial topic. J Trauma. 1999;47(2):426–35.PubMedCrossRefGoogle Scholar
  62. 62.
    Van U. Inhibition of toxin production in Clostridium perfringens in vitro by hyperbaric oxygen. Antonie Van Leeuwenhoek. 1965;31:181–6.CrossRefGoogle Scholar
  63. 63.
    Wilkinson D, Doolette D. Hyperbaric oxygen treatment and survival from necrotizing soft tissue infection. Arch Surg. 2004;139(12):1339–45.PubMedCrossRefGoogle Scholar
  64. 64.
    Riseman JA, et al. Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery. 1990;108(5):847–50.PubMedGoogle Scholar
  65. 65.
    Escobar SJ, et al. Adjuvant hyperbaric oxygen therapy (HBO2)for treatment of necrotizing fasciitis reduces mortality and amputation rate. Undersea Hyperb Med. 2005;32(6):437–43.PubMedGoogle Scholar
  66. 66.
    Soh CR, et al. Hyperbaric oxygen therapy in necrotising soft tissue infections: a study of patients in the United States Nationwide Inpatient Sample. Intensive Care Med. 2012;38(7):1143–51.PubMedCrossRefGoogle Scholar
  67. 67.
    Brown DR, et al. A multicenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy. Am J Surg. 1994;167(5):485–9.PubMedCrossRefGoogle Scholar
  68. 68.
    Shupak A, et al. Necrotizing fasciitis: an indication for hyperbaric oxygenation therapy? Surgery. 1995;118(5):873–8.PubMedCrossRefGoogle Scholar
  69. 69.
    Darenberg J, et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2003;37(3):333–40.PubMedCrossRefGoogle Scholar
  70. 70.
    Kaul R, et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome – a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis. 1999;28(4):800–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of SurgeryMassachusetts General HospitalBostonUSA
  2. 2.Division of Trauma Emergency Surgery, and Surgical Critical CareMassachusetts General HospitalBostonUSA

Personalised recommendations